36:
332:
295:
208:
are important endogenous vasoactive substances. Vasoactive drug therapy is typically used when a patient has the blood pressure and heart rate
373:
287:
119:
258:. The use of vasoactive agents for patients with pulmonary hypertension may cause harm and unnecessary expense to persons with
255:
57:
100:
205:
53:
181:
72:
397:
251:
79:
46:
366:
291:
86:
223:
Vasoactive drugs are typically administered using a volumetric infusion device (IV pump). This category of
161:
68:
209:
359:
267:
213:
165:
141:
240:
343:
173:
304:
300:
227:
require close observation of the patient with near immediate intervention required by the
217:
93:
392:
145:
386:
259:
339:
201:
185:
169:
157:
232:
189:
177:
35:
27:
Endogenous agent or pharmaceutical drug that affects blood pressure / heart rate
247:
236:
193:
149:
137:
263:
228:
197:
216:
is typically titrated (adjusted up or down) to achieve a desired effect or
331:
17:
231:
in charge of the patient's care. Important vasoactive substances are
308:, American College of Chest Physicians and American Thoracic Society
254:, and endothelin antagonists, are approved for the treatment of
224:
29:
347:
144:
that has the effect of either increasing or decreasing
296:"Five Things Physicians and Patients Should Question"
60:. Unsourced material may be challenged and removed.
367:
8:
374:
360:
120:Learn how and when to remove this message
156:, that is, vascular activity (effect on
279:
220:as determined by competent clinicians.
7:
328:
326:
288:American College of Chest Physicians
58:adding citations to reliable sources
246:Various vasoactive agents, such as
346:. You can help Knowledge (XXG) by
25:
330:
34:
256:pulmonary arterial hypertension
45:needs additional citations for
1:
206:vasoactive intestinal peptide
252:phosphodiesterase inhibitors
188:under control. For example,
414:
325:
292:American Thoracic Society
182:renin–angiotensin system
180:mechanisms (such as the
303:: an initiative of the
342:-related article is a
176:, it helps the body's
168:, typically through
54:improve this article
241:adrenergic agonists
166:vascular resistance
162:vascular compliance
142:pharmaceutical drug
398:Pharmacology stubs
294:(September 2013),
260:left heart disease
355:
354:
130:
129:
122:
104:
16:(Redirected from
405:
376:
369:
362:
334:
327:
317:
316:
315:
313:
284:
212:constantly. The
174:vasoconstriction
160:). By adjusting
136:substance is an
125:
118:
114:
111:
105:
103:
62:
38:
30:
21:
413:
412:
408:
407:
406:
404:
403:
402:
383:
382:
381:
380:
323:
321:
320:
311:
309:
305:ABIM Foundation
301:Choosing Wisely
286:
285:
281:
276:
218:range of values
126:
115:
109:
106:
63:
61:
51:
39:
28:
23:
22:
15:
12:
11:
5:
411:
409:
401:
400:
395:
385:
384:
379:
378:
371:
364:
356:
353:
352:
335:
319:
318:
278:
277:
275:
272:
239:-1, and alpha-
146:blood pressure
128:
127:
69:"Vasoactivity"
42:
40:
33:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
410:
399:
396:
394:
391:
390:
388:
377:
372:
370:
365:
363:
358:
357:
351:
349:
345:
341:
336:
333:
329:
324:
307:
306:
302:
297:
293:
289:
283:
280:
273:
271:
269:
268:lung diseases
265:
261:
257:
253:
249:
244:
242:
238:
234:
230:
226:
221:
219:
215:
211:
207:
203:
199:
195:
191:
187:
183:
179:
175:
171:
167:
163:
159:
158:blood vessels
155:
151:
147:
143:
139:
135:
124:
121:
113:
102:
99:
95:
92:
88:
85:
81:
78:
74:
71: –
70:
66:
65:Find sources:
59:
55:
49:
48:
43:This article
41:
37:
32:
31:
19:
348:expanding it
340:pharmacology
337:
322:
310:, retrieved
299:
282:
245:
222:
202:nitric oxide
186:hemodynamics
170:vasodilation
154:vasoactivity
153:
152:through its
133:
131:
116:
107:
97:
90:
83:
76:
64:
52:Please help
47:verification
44:
248:prostanoids
233:angiotensin
190:angiotensin
178:homeostatic
387:Categories
274:References
237:endothelin
229:clinicians
194:bradykinin
184:) to keep
150:heart rate
138:endogenous
134:vasoactive
80:newspapers
18:Vasoactive
312:6 January
266:types of
264:hypoxemic
210:monitored
198:histamine
140:agent or
110:May 2010
148:and/or
94:scholar
214:dosage
204:, and
96:
89:
82:
75:
67:
393:Drugs
338:This
235:-11,
225:drugs
101:JSTOR
87:books
344:stub
314:2013
172:and
164:and
73:news
262:or
56:by
389::
298:,
290:;
270:.
250:,
243:.
200:,
196:,
192:,
132:A
375:e
368:t
361:v
350:.
123:)
117:(
112:)
108:(
98:·
91:·
84:·
77:·
50:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
